There Is 1 Big Thing to Watch With CELH Stock in 2026

Celsius Holdings has outperformed the market, rising roughly 37% YTD, driven largely by its transformative acquisition of Alani Nu for $1.8 billion (net $1.65 billion after a tax benefit) that closed in early Q2 2025 and expanded its demographic reach at an attractive valuation. The deal helped produce an 84% revenue jump in Q2 and a 173% gain in the latest report alongside back‑to‑back earnings beats; analysts forecast $3.2 billion in consolidated 2026 revenue (+32%) with a modeled 114% Y/Y lift in Q1 because Alani Nu was not included in the prior year, but Q2 2026 will be the critical apples‑to‑apples test of sustainable organic growth. Momentum and market‑share gains underpin the bullish case, yet the stock has pulled back from its peak and investors should watch whether margins and top‑line growth hold once comparisons normalize; disclosure: the author and The Motley Fool own positions in Celsius.

Analysis

Celsius Holdings has outperformed the market in 2025, with shares up roughly 37% year-to-date versus the S&P 500's 16% return, though the stock has retraced about one-third from its peak. The primary catalyst was the February acquisition of Alani Nu for $1.8 billion (net $1.65 billion after a one-time tax benefit), a deal that closed at the start of Q2 2025 and expanded Celsius's demographic reach into a female-oriented lifestyle segment at a valuation below Celsius's trailing sales and projected EBITDA.

Operationally the acquisition reversed three quarters of prior revenue declines: consolidated revenue rose 84% in Q2 and 173% in the latest report, and the company delivered back-to-back positive earnings surprises. Analysts model $3.2 billion in revenue for 2026 (+32%), with a front-loaded 114% year-over-year lift expected in Q1 because Alani Nu was not included in last year's Q1; management will face an apples-to-apples test in Q2 2026 to validate organic growth and margin sustainability.

Momentum and market-share gains support a constructive sentiment (article signals show moderately positive tone and a per-ticker sentiment of 0.6 for CELH), but the risk set is clear: integration execution, whether Alani Nu can sustain growth without acquisition-driven comparisons, and potential margin pressure when transitory benefits normalize. The key near-term catalysts are Q1 and especially Q2 2026 results, guidance versus the $3.2 billion consensus, and concrete evidence of organic recovery in the flagship Celsius brand.

Key Decisions for Investors

• Investors should closely watch Q2 2026 consolidated revenue and EBITDA margins as the critical apples-to-apples test; positive results would support adding to positions
• It may be prudent to scale into or hold existing positions with downside protection (e.g., stop-losses or options hedges) given the stock has pulled back a third from its peak and growth is currently acquisition-driven
• Reassess exposure if Q2 shows significant margin compression or a slowdown in organic Celsius brand sales relative to analyst models, as that would undermine the 2026 $3.2 billion revenue thesis
• Monitor integration KPIs from Alani Nu (female consumer demand, SKU performance, cost synergies) and any guidance revisions from management before increasing conviction